17 results
8-K
EX-99.1
LUMO
Lumos Pharma Inc
6 May 22
Other Events
4:37pm
hormone secretagogue, could prove to be an efficacious therapeutic for those suffering from this chronic liver disease.”
“Lumos Pharma is honored
8-K/A
LUMO
Lumos Pharma Inc
1 Jun 20
Other Events
12:00am
juvenile and chronic toxicology studies running concurrently with the Phase 1 clinical trial observed for the compound and the program was discontinued … of LUM-201, consistent with the intended clinical dose frequency and route. The toxicology studies completed by Merck with LUM-201 include acute, chronic
DEFR14A
5i69 52y10lzmkn6puf
13 Feb 20
Revised proxy
4:37pm
DEFM14A
1mmx3vg
10 Feb 20
Proxy related to merger
8:30am
PRER14A
x92xr
9 Jan 20
Preliminary revised proxy
8:02am
PREM14A
kr1cut7g3m5m3n
20 Nov 19
Preliminary proxy related to merger
6:38am
10-K
klt g5l75u
30 Mar 12
Annual report
12:00am
- Prev
- 1
- Next